Search - tctmd.com

Displaying 761 - 780 of 5342

Sort: Relevancy | Date

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

News Daily News

QCA an Alternative to IVUS? GUIDE-DES Trial Hints at the Possibility

Caitlin E. Cox

March 20, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

News Daily News

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

Caitlin E. Cox

March 12, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Daily News

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Yael L. Maxwell

March 07, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

Presentation THT 2024

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Presenter: Mariell Jessup

March 05, 2024

Presentation THT 2024

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

Presenter: Harriette G.C. Van Spall

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

Reducing Congestion by Removing Fluid From the Interstitium

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Advertisement

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

QCA an Alternative to IVUS? GUIDE-DES Trial Hints at the Possibility

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Patients With CKD Remain Underrepresented in Trials of CV Meds

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

The Conundrum of Clinical Trials in Cardiogenic Shock

Semaglutide Winning Streak Continues in CKD With FLOW

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

Debating the Role of T-TEER in the Sickest Patients

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Reducing Congestion by Removing Fluid From the Interstitium

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content